Abstract: The present invention relates to ophthalmic preparations in the form of eyedrops based on BDNF (Brain-Derived Neurotrophic Factor). Said preparations can be administered topically to the intact eye surface, and are useful in the prevention and treatment of neurodegenerative disorders of the retina, optic nerve, lateral geniculate body and visual cortex, in order to prevent reduction of visual capacity and restore the normal visual function.
Type:
Grant
Filed:
November 12, 2010
Date of Patent:
July 12, 2016
Assignee:
HMFRA HUNGARY LIMITED LIABILITY COMPANY
Inventors:
Luciano Domenici, Luca Giovannini, Marco Sanso′
Abstract: The present invention relates to ophthalmic preparations in the form of eyedrops based on PACAP (Pituitary Adenylate Cyclase Activating Polypeptide) which restore the normal visual function in retinal dystrophy/retinopathy and optic neuropathy, with special reference to glaucoma. Said preparations can be administered topically to the intact eye surface, and are useful in the treatment of various forms of retinal dystrophy/retinopathy and optic neuropathy, such as glaucoma.
Type:
Application
Filed:
April 5, 2012
Publication date:
October 23, 2014
Applicant:
HMFRA HUNGARY LIMITED LIABILITY COMPANY
Inventors:
Luciano Domenici, Marco Sanso', Luca Giovannini
Abstract: Said preparations can be administered topically to the intact eye surface, and are useful in the prevention and treatment of neurodegenerative disorders of the retina, optic nerve, lateral geniculate body and visual cortex, in order to prevent reduction of visual capacity and restore the normal visual function.
Type:
Application
Filed:
November 12, 2010
Publication date:
October 11, 2012
Applicant:
HMFRA HUNGARY LIMITED LIABILITY COMPANY
Inventors:
Luciano Domenici, Luca Giovannini, Marco Sanso'